Refsum Disease, Infantile: Clinical Trials

4 trials for Refsum Disease, Infantile, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 active not recruiting, 1 terminated. 2 Phase 3, 1 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2
Not applicable1Terminated 1
Phase 21Active not recruiting 1

Follow Refsum Disease, Infantile: new trials by email Literature Review of Refsum Disease, Infantile trials Research Report on Refsum Disease, Infantile

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis
Stem Cell Transplantation, IMD Preparative Regimen, Osteopetrosis Only Preparative Regimen - Mucopolysaccharidosis Disorders, Hurler Syndrome
Phase 2Active not recruitingMasonic Cancer Center, University of Minnesota1492014-07-102026-11-03
Betaine and Peroxisome Biogenesis Disorders
Betaine - Peroxisome Biogenesis Disorders
Phase 3CompletedMcGill University Health Centre/Research Institute of the McGill University Health Centre122013-03-012016-06-28
Compassionate Treatment of Patients With Inborn Errors of Bile Acid Metabolism With Cholic Acid
Cholic Acids - Infantile Refsum's Disease, Zellweger Syndrome
Phase 3CompletedMirum Pharmaceuticals, Inc.851992-01-012023-10-03
Study of Bile Acids in Patients With Peroxisomal Disorders
chenodeoxycholic acid, cholic acid, ursodiol - Infantile Refsum's Disease, Zellweger Syndrome
Not applicableTerminatedUniversity of Cincinnati252015-03-25

Narrower conditions

Peroxisomal Disorders (4)  ·  Zellweger Syndrome (4)  ·  Adrenoleukodystrophy (2)  ·  Pseudo-Zellweger syndrome (2)  ·  Sphingolipidoses (2)  ·  Alpha-Methylacyl-CoA Racemase Deficiency (1)  ·  Aspartylglucosaminuria (1)  ·  Cholestasis (1)  ·  Fucosidosis (1)  ·  Hereditary Diffuse Leukoencephalopathy with Spheroids (1)  ·  Leukodystrophy, Globoid Cell (1)  ·  Leukodystrophy, Metachromatic (1)  ·  Metabolism, Inborn Errors (1)  ·  Mucopolysaccharidosis I (1)

Broader conditions

Abnormalities, Multiple (4)  ·  Brain Diseases (4)  ·  Brain Diseases, Metabolic (4)  ·  Brain Diseases, Metabolic, Inborn (4)  ·  Central Nervous System Diseases (4)  ·  Congenital Abnormalities (4)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4)  ·  Digestive System Diseases (4)  ·  Female Urogenital Diseases (4)  ·  Female Urogenital Diseases and Pregnancy Complications (4)  ·  Genetic Diseases, Inborn (4)  ·  Kidney Diseases (4)  ·  Liver Diseases (4)  ·  Male Urogenital Diseases (4)  ·  Metabolic Diseases (4)

Interventions

Cholic Acid (2)  ·  Betaine (1)  ·  Chenodeoxycholic Acid (1)  ·  Cholic Acids (1)  ·  Regimen B (1)  ·  Stem Cell Transplantation (1)  ·  Ursodeoxycholic Acid (1)

Sponsors

Masonic Cancer Center, University of Minnesota (1)  ·  McGill University Health Centre/Research Institute of the McGill University Health Centre (1)  ·  Mirum Pharmaceuticals, Inc. (1)  ·  University of Cincinnati (1)

Countries

United States (2)  ·  Canada (1)

Top investigators

James Heubi, MD (1)  ·  Kenneth Setchell (1)  ·  Kenneth Setchell, PhD (1)  ·  Nancy Braverman, PhD, MD (1)  ·  Paul Orchard, M.D. (1)

Results publications

PMID 28644367